
Search
Selected Filter
Filter Results
Displaying 81–90 of 521 news results
-
Feb 15, 2024
The May 9th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Feb 13, 2024
The free, online event on March 20, 2024, will feature presentations from Rachel Huckfeldt, MD, PhD, Mass Eye and Ear, and Rachelle Lin, OD, Ketchum University.
-
Feb 9, 2024
The company plans to begin a Phase 2/3 clinical trial for the treatment during the first half of 2024.
-
Feb 6, 2024
Foundation Fighting Blindness Launches GYROS, a Natural History Study for People with Gyrate Atrophy
Gyrate atrophy is an inherited retinal disease—causing progressive vision loss. GYROS results will help researchers design clinical trials for an emerging gyrate atrophy gene therapy.
-
Feb 1, 2024
Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy
ACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.
-
Dec 11, 2023
Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials
-
Nov 29, 2023
Foundation Fighting Blindness Appoints Jeff Klaas as Chief Strategy and Innovation Officer
Klaas brings over twenty years of experience to lead strategies aimed at elevating engagement and revenue.
-
Nov 8, 2023
Kiora Reports Vision Restoration in Phase 1/2 Clinical Trial for Photoswitch Therapy
The company’s molecule is designed to restore some vision to people with ultra-low or no vision caused by advanced retinitis pigmentosa and other retinal diseases.
-
Nov 2, 2023
New Report: Vitamin A Supplementation Provides No Vision Benefit to RP Patients
The report also concludes that vitamin E supplementation accelerates vision loss for RP patients
-
Nov 2, 2023
First of its Kind Collaboration Marries Genomics Data with World’s Largest Database of Ophthalmologic Patient Encounters to Improve Accuracy of Clinical Research.